BEGIN:VCALENDAR VERSION:2.0 X-WR-CALNAME;VALUE=TEXT:QBRI-HSCI Symposium PRODID:-//Harvard events data//EN BEGIN:VEVENT UID:event_1626305_0 SUMMARY:QBRI-HSCI Symposium DESCRIPTION:

Please join us for a symposium on type 1 diabetes presented by the Harvard Stem Cell Institute (HSCI) and Qatar Biomedical Research Institute (QBRI), focused on the latest advances in beta cell differentiation, cell replacement therapy, and autoimmune protection.

8:00-8:15 | WELCOME
Larry Stanton, with remarks by Doug Melton and Omar El-Agnaf

8:15-8:55
Evolving role for beta cell replacement in Type I diabetes
Jim Markmann, MD, PhD
Claude E. Welch Professor of Surgery, Massachusetts General Hospital

8:55-9:10
Navigating beta cell differentiation via genome-wide loss-of-function screening
Adrian Veres, PhD | HSCI Trainee
Postdoctoral Research Fellow, Harvard University

9:10-9:55
Towards a robust manufacturing process for autologous iPSC-based therapies.
Ruud Hulspas, PhD
Director Process Development, Dana-Farber Cancer Institute

9:55-10:20 | BREAK

10:20-11:00
Genome-wide in vivo CRISPR screen in the study of pancreatic beta cell protection against autoimmune destruction in T1D
Peng Yi, PhD
Assistant Investigator and Co-Director, Genome Editing Core, Joslin Diabetes Center

11:00-11:40
Immune Barriers to Beta Cell Replacement
Jason Gaglia, MD, MMSc
Director of Hood Center for the Prevention of Childhood Diabetes, Joslin Diabetes Center

11:40-11:50 | WRAP UP + THANK YOU
Larry Stanton

LOCATION:Virtual, via Zoom - register to receive the link via email STATUS:CONFIRMED DTSTART:20220110T130000Z DTEND:20220110T170000Z END:VEVENT END:VCALENDAR